Angiography Device Market By Application (Therapeutic, Diagnostic), By End User (Academic Research Laboratories, Hospital, Diagnostic Center), By Types Of Procedure (Micro Angiography, Non-Coronary Angiography, Coronary Angiography), By Products (Guide Wire, Angiography System, Catheter Tube, Balloon), By Technology (MR Angiography Devices, X-Ray Angiography, Flat-Panel Detectors, Image Intensifiers, CT Angiography) , Industry Size, Growth, Share And Forecast To 2022

Published By: Brisk Insights | Published On: Jul 26, 2016

Key Findings


The global angiography market is expected to grow with a CAGR of 5.1%and the revenue is estimated to grow around $32,246.15 million during the forecast period of 2016-2022. Angiography is the X-ray imaging of blood vessels by utilizing contrast agents administered into the bloodstream with the use of thin plastic tube (catheter) which is positioned directly in the blood vessel. The images captured are known as angiograms. Angiography gives information about abnormalities of blood vessel such as abnormal widening, narrowing, blockage, bleeding, and inflammation by using a liquid contrast agent (known as contrast medium). Contrast agents are introduced into an artery or vein to produce the blood vessels which is seen on X-rays. Angiography is also utilized to guide steps that cureabnormalities ofblood vessel. A tiny balloon can be inflated, if the artery is narrowed, (and sometimes a bit of metal tubing known as stent can be placed)


The key factor that is helpful in driving the angiography device market is technological advancements. CT angiography is one of the largest innovations in imaging technologies. In the procedure, contrast material, a material that makes it simple to watch tissue in an X-ray is placed through the catheter. Then an X-ray is captured of the area to see internal bleeding, blockages, and other problems. It sometimes needs sedatives and often a night in the hospital. It also has risks, like a little possibility of bleeding or blood clots. The new and advanced CT scans enables a fully noninvasive way to capture the same information,just like an invasive catheter angiography. In the procedure through CT angiography, the doctor just places the contrast object into the arm and captures a CT scan. The arteries in the legs, brain, kidneys, and lungs can then easily be examined. The complete procedure takes only 10-25 minutes. It’s cheaper, faster, and safer than the former invasive method. Thus, technological advancements is the major reason for the growth of the angiography devices market.


Some more key factors that are helpful in driving the market are rising demand for advanced technologies such as CT and MRA; rising aging population; and, the growing prevalence of cardiovascular diseases, along with the rising health awareness about the early diagnosis and treatment of diseases. The market is facing some restraints too, such as regulatory framework and some health problems that are noticed in some patients due to angiography.
The market has huge opportunities due to supportive government policies, rising demand from emerging economies, and rising investment from the public & private sector. The market is facing a cost challenge i.e. the huge cost of digital angiography devices.


Market Segment Insight


Angiography market is segmented on the basis of application; end users; types of procedure; symptoms; and, geography. On the basis of application, the market is sub segmented into therapeutic and diagnostic applications.


On the basis of end users, the market is sub segmented into academic research laboratories; and, hospitals and diagnostic centers.
On the basis of types of procedure, the market is sub segmented into micro angiography; non-coronary angiography; coronary angiography; and, others. Non-coronary angiography is again segmented into peripheral angiography and neuro-vascular angiography.


On the basis of products, the market is sub segmented into guide wires; angiography system; catheters tube; balloons; and, others.
On the basis of technology, the market is sub segmented into MR angiography devices; X-ray angiography devices; and CT angiography devices. X-ray angiography is further sub segmented into flat-panel detectors and image intensifiers.


On the basis of symptoms, the market is sub segmented into valvular heart disease; congestive heart failure; congenital heart failure; and, other symptoms.


X-ray flat panel detectors had the highest market share in 2014, due to huge applicability in many segments i.e. security, medical, dental, industrial, and veterinary. CT angiography devices are estimated to increase during the forecast period due to shifting preferences from X-ray angiography.

 

Regional Insight


On the basis of geography, the market is segmented into North America, Europe, Asia pacific and RoW. North America was the highest market in 2014, followed by Europe and Asia Pacific. North America is dominating the market due to the availability of proper established healthcare infrastructure. The trend such as transformed old technologies with the new and advanced technologies is estimated to drive the demand for angiography devices market in the North American region. Asia pacific is expected to be the fastest growing region during the forecast period due to improving healthcare infrastructure, increasing volume of biotechnology firms, and rising investment from the biotechnology firms are the major drivers for the emergence of angiography devices market in the regions of Asia Pacific. Emerging economies like India and China is expected to drive the market of Asia Pacific region due to rising cases of cardiovascular diseases in thesecountries. Brazil has also witnessed growth opportunities in this market.


Competitive Insights


Some of the major players in the global angiography devices market are: Abbott Labs; Allengers medical systems Ltd.; Biomed Ltd.; Boston Scientific Corporation; Cordis Corporation; Esaote; GE healthcare; Hitachi Medical Systems America, Inc.; Medtronic, Inc. (U.S.);Nidek Co. Ltd.; Royal Philips Electronics; Shimadzu Corporation (Japan); Siemens Healthcare (Germany); St. Jude Medical, Inc. (U.S.); Toshiba Medical Systems Corporation (Japan). These players have adopted key strategies such as mergers, acquisitions, agreement, product launch, etc. to expand their market share globally; and, one of the key strategy adopted by Nidek Co. Ltd.are as follows: On December 2015, NIDEK launches AngioScan OCT Angiography Software for RS-3000 Advance.The working of RS-3000 Advance mixed with this software enables assessment of retina in larger information supporting with the diagnosis and increasing patient care.

CHAP 1. METHODOLOGY & SCOPE 14
1.1. RESEARCH METHODOLOGY 14
1.2. RESEARCH SCOPE & ASSUMPTIONS 14
1.3. LIST OF DATA SOURCES 14


CHAP 2. EXECUTIVE SUMMARY 15
2.1. GLOBAL ANGIOGRAPHY DEVICE MARKET SUMMARY & KEY BUYING CRITERIA 15
2.2. GLOBAL ANGIOGRAPHY DEVICE MARKET OUTLOOK 15
2.3. MARKET SEGMENTATION ANALYSIS 15
2.4. MARKET SIZE AND GROWTH PROSPECTS 2012-2022 15
2.5. GLOBAL ANGIOGRAPHY DEVICE MARKET VALUE CHAIN ANALYSIS 15
2.6. VENDOR LANDSCAPE 15


CHAP 3. GLOBAL ANGIOGRAPHY DEVICE MARKET 16
3.1. MARKET DRIVER ANALYSIS 16
3.1.1. RISING DEMAND FOR ADVANCED TECHNOLOGIES 16
3.1.2. RISING AGING POPULATION AND PREVALENCE OF CARDIOVASCULAR DISEASES 16
3.1.3. RISING HEALTH AWARENESS ABOUT THE EARLY DIAGNOSIS & TREATMENT 16
3.1.4. TECHNOLOGICAL ADVANCEMENTS 16
3.2. MARKET RESTRAINT ANALYSIS 16
3.2.1. CERTAIN HEALTH PROBLEMS NOTICED IN SOME PATIENTS DUE TO ANGIOGRAPHY 16
3.2.2. REGULATORY FRAMEWORK 16
3.3. KEY OPPORTUNITIES 16
3.3.1. SUPPORTIVE GOVERNMENT POLICIES 16
3.3.2. RISING DEMAND FROM EMERGING ECONOMIES 16
3.3.3. RISING INVESTMENT FROM THE PUBLIC AND PRIVATE SECTOR 16
3.4. CHALLENGES 16
3.4.1. HUGE COST OF DIGITAL ANGIOGRAPHY DEVICES 16


CHAP 4. INDUSTRY ANALYSIS 17
4.1. GLOBAL ANGIOGRAPHY DEVICE MARKET– PORTER’S FIVE FORCE MODEL 17
4.2. GLOBAL ANGIOGRAPHY DEVICE MARKET– PESTEL ANALYSIS 17
4.3. GLOBAL ANGIOGRAPHY DEVICE MARKET– GAP ANALYSIS 17


CHAP 5. GLOBAL ANGIOGRAPHY DEVICE MARKET BY APPLICATION 2012-2022 ($ MILLION) 18
5.1. GLOBAL ANGIOGRAPHY DEVICE MARKET BY THERAPEUTIC 2012-2022 ($ MILLION) 18
5.2. GLOBAL ANGIOGRAPHY DEVICE MARKET BY DIAGNOSTIC 2012-2022 ($ MILLION) 18


CHAP 6. GLOBAL ANGIOGRAPHY DEVICE MARKET BY END USER 2012-2022 ($ MILLION) 19
6.1. GLOBAL ANGIOGRAPHY DEVICE MARKET BY ACADEMIC RESEARCH LABORATORIES 2012-2022 ($ MILLION) 19
6.2. GLOBAL ANGIOGRAPHY DEVICE MARKET BY HOSPITAL 2012-2022 ($ MILLION) 19
6.3. GLOBAL ANGIOGRAPHY DEVICE MARKET BY DIAGNOSTIC CENTER 2012-2022 ($ MILLION) 19


CHAP 7. GLOBAL ANGIOGRAPHY DEVICE MARKET BY TYPES OF PROCEDURE 2012-2022 ($ MILLION) 20
7.1. GLOBAL ANGIOGRAPHY DEVICE MARKET BY MICRO ANGIOGRAPHY 2012-2022 ($ MILLION) 20
7.2. GLOBAL ANGIOGRAPHY DEVICE MARKET BY NON-CORONARY ANGIOGRAPHY 2012-2022 ($ MILLION) 20
7.2.1. GLOBAL ANGIOGRAPHY DEVICE MARKET BY PERIPHERAL ANGIOGRAPHY 2012-2022 ($ MILLION) 20
7.2.2. GLOBAL ANGIOGRAPHY DEVICE MARKET BY NEURO-VASCULAR ANGIOGRAPHY 2012-2022 ($ MILLION) 20
7.3. GLOBAL ANGIOGRAPHY DEVICE MARKET BY CORONARY ANGIOGRAPHY 2012-2022 ($ MILLION) 20
7.4. GLOBAL ANGIOGRAPHY DEVICE MARKET BY OTHER PROCEDURES 2012-2022 ($ MILLION) 20


CHAP 8. GLOBAL ANGIOGRAPHY DEVICE MARKET BY PRODUCTS 2012-2022 ($ MILLION) 21
8.1. GLOBAL ANGIOGRAPHY DEVICE MARKET BY GUIDE WIRE 2012-2022 ($ MILLION) 21
8.2. GLOBAL ANGIOGRAPHY DEVICE MARKET BY ANGIOGRAPHY SYSTEM 2012-2022 ($ MILLION) 21
8.3. GLOBAL ANGIOGRAPHY DEVICE MARKET BY CATHETER TUBE 2012-2022 ($ MILLION) 21
8.4. GLOBAL ANGIOGRAPHY DEVICE MARKET BY BALLOON 2012-2022 ($ MILLION) 21
8.5. GLOBAL ANGIOGRAPHY DEVICE MARKET BY OTHERS 2012-2022 ($ MILLION) 21


CHAP 9. GLOBAL ANGIOGRAPHY DEVICE MARKET BY TECHNOLOGY 2012-2022 ($ MILLION) 22
9.1. GLOBAL ANGIOGRAPHY DEVICE MARKET BY MR ANGIOGRAPHY DEVICES 2012-2022 ($ MILLION) 22
9.2. GLOBAL ANGIOGRAPHY DEVICE MARKET BY X-RAY ANGIOGRAPHY DEVICES 2012-2022 ($ MILLION) 22
9.2.1. GLOBAL ANGIOGRAPHY DEVICE MARKET BY FLAT-PANEL DETECTORS 2012-2022 ($ MILLION) 22
9.2.2. GLOBAL ANGIOGRAPHY DEVICE MARKET BY IMAGE INTENSIFIERS 2012-2022 ($ MILLION) 22
9.3. GLOBAL ANGIOGRAPHY DEVICE MARKET BY CT ANGIOGRAPHY DEVICES 2012-2022 ($ MILLION) 22


CHAP 10. GLOBAL ANGIOGRAPHY DEVICE MARKET BY SYMPTOMS 2012-2022 ($ MILLION) 23
10.1. GLOBAL ANGIOGRAPHY DEVICE MARKET BY VALVULAR HEART DISEASE 2012-2022 ($ MILLION) 23
10.2. GLOBAL ANGIOGRAPHY DEVICE MARKET BY CONGESTIVE HEART FAILURE 2012-2022 ($ MILLION) 23
10.3. GLOBAL ANGIOGRAPHY DEVICE MARKET BY CONGENITAL HEART FAILURE 2012-2022 ($ MILLION) 23
10.4. GLOBAL ANGIOGRAPHY DEVICE MARKET BY OTHER SYMPTOMS 2012-2022 ($ MILLION) 23


CHAP 11. GLOBAL ANGIOGRAPHY DEVICE MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 24
11.1. GLOBAL ANGIOGRAPHY DEVICE MARKET BY REGION 2012-2022 ($ MILLION) 24
11.2. NORTH AMERICA 24
11.2.1. NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
11.2.2. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
11.2.3. NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 24
11.2.3.1. U.S. 24
11.2.3.1.1. U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
11.2.3.1.2. U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
11.2.3.2. CANADA 24
11.2.3.2.1. CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
11.2.3.2.2. CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
11.3. EUROPE 24
11.3.1. EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 24
11.3.2. EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 24
11.3.3. EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 24
11.3.3.1. GERMANY 24
11.3.3.1.1. GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
11.3.3.1.2. GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
11.3.3.2. UK 25
11.3.3.2.1. UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
11.3.3.2.2. UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
11.3.3.3. FRANCE 25
11.3.3.3.1. FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
11.3.3.3.2. FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
11.3.3.4. SPAIN 25
11.3.3.4.1. SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
11.3.3.4.2. SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
11.3.3.5. REST OF EUROPE 25
11.3.3.5.1. RUSSIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
11.3.3.5.2. RUSSIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
11.3.3.5.3. OTHERS MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 25
11.3.3.5.4. OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 25
11.4. ASIA PACIFIC 26
11.4.1. ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
11.4.2. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
11.4.3. ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 26
11.4.3.1. CHINA 26
11.4.3.1.1. CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
11.4.3.1.2. CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
11.4.3.2. INDIA 26
11.4.3.2.1. INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
11.4.3.2.2. INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 26
11.4.3.3. JAPAN 26
11.4.3.3.1. JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
11.4.3.3.2. JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 26
11.4.3.4. SOUTH KOREA 26
11.4.3.4.1. SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 26
11.4.3.4.2. SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 26
11.4.3.5. OTHERS 26
11.4.3.5.1. OTHER MARKET ESTIMATES AND FORECASTS 2012-2022 ($ MILLION) 27
11.4.3.5.2. OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
11.5. MIDDLE EAST & AFRICA 27
11.5.1. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
11.5.2. MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
11.6. LATIN AMERICA 27
11.6.1. LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
11.6.2. LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27
11.6.2.1. BRAZIL 27
11.6.2.1.1. BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 27
11.6.2.1.2. BRAZIL MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 27


CHAP 12. COMPETITIVE LANDSCAPE 28
12.1. ABBOTT LABS 29
12.1.1. COMPANY OVERVIEW 29
12.1.2. SCOT ANALYSIS 29
12.1.3. PRODUCT BENCHMARKING 29
12.1.4. STRATEGIC INITIATIVES 29
12.2. ALLENGERS MEDICAL SYSTEMS LTD. 29
12.2.1. COMPANY OVERVIEW 29
12.2.2. SCOT ANALYSIS 29
12.2.3. PRODUCT BENCHMARKING 29
12.2.4. STRATEGIC INITIATIVES 29
12.3. BIOMED LTD. 29
12.3.1. COMPANY OVERVIEW 29
12.3.2. SCOT ANALYSIS 29
12.3.3. PRODUCT BENCHMARKING 29
12.3.4. STRATEGIC INITIATIVES 29
12.4. BOSTON SCIENTIFIC CORPORATION 29
12.4.1. COMPANY OVERVIEW 29
12.4.2. SCOT ANALYSIS 29
12.4.3. PRODUCT BENCHMARKING 29
12.4.4. STRATEGIC INITIATIVES 29
12.5. CORDIS CORPORATION 29
12.5.1. COMPANY OVERVIEW 29
12.5.2. SCOT ANALYSIS 29
12.5.3. PRODUCT BENCHMARKING 29
12.5.4. STRATEGIC INITIATIVES 29
12.6. ESAOTE 29
12.6.1. COMPANY OVERVIEW 29
12.6.2. SCOT ANALYSIS 30
12.6.3. PRODUCT BENCHMARKING 30
12.6.4. STRATEGIC INITIATIVES 30
12.7. GE HEALTHCARE 30
12.7.1. COMPANY OVERVIEW 30
12.7.2. SCOT ANALYSIS 30
12.7.3. PRODUCT BENCHMARKING 30
12.7.4. STRATEGIC INITIATIVES 30
12.8. HITACHI MEDICAL SYSTEMS AMERICA, INC. 30
12.8.1. COMPANY OVERVIEW 30
12.8.2. SCOT ANALYSIS 30
12.8.3. PRODUCT BENCHMARKING 30
12.8.4. STRATEGIC INITIATIVES 30
12.9. MEDTRONIC, INC. (U.S.) 30
12.9.1. COMPANY OVERVIEW 30
12.9.2. SCOT ANALYSIS 30
12.9.3. PRODUCT BENCHMARKING 30
12.9.4. STRATEGIC INITIATIVES 30
12.10. NIDEK CO. LTD. 30
12.10.1. COMPANY OVERVIEW 30
12.10.2. SCOT ANALYSIS 30
12.10.3. PRODUCT BENCHMARKING 30
12.10.4. STRATEGIC INITIATIVES 30
12.11. ROYAL PHILIPS ELECTRONICS 30
12.11.1. COMPANY OVERVIEW 30
12.11.2. SCOT ANALYSIS 30
12.11.3. PRODUCT BENCHMARKING 30
12.11.4. STRATEGIC INITIATIVES 30
12.12. SHIMADZU CORPORATION (JAPAN) 31
12.12.1. COMPANY OVERVIEW 31
12.12.2. SCOT ANALYSIS 31
12.12.3. PRODUCT BENCHMARKING 31
12.12.4. STRATEGIC INITIATIVES 31
12.13. SIEMENS HEALTHCARE (GERMANY) 31
12.13.1. COMPANY OVERVIEW 31
12.13.2. SCOT ANALYSIS 31
12.13.3. PRODUCT BENCHMARKING 31
12.13.4. STRATEGIC INITIATIVES 31
12.14. ST. JUDE MEDICAL, INC. (U.S) 31
12.14.1. COMPANY OVERVIEW 31
12.14.2. SCOT ANALYSIS 31
12.14.3. PRODUCT BENCHMARKING 31
12.14.4. STRATEGIC INITIATIVES 31
12.15. TOSHIBA MEDICAL SYSTEMS CORPORATION 31
12.15.1. COMPANY OVERVIEW 31
12.15.2. SCOT ANALYSIS 31
12.15.3. PRODUCT BENCHMARKING 31
12.15.4. STRATEGIC INITIATIVES 31

TABLE 1 GLOBAL ANGIOGRAPHY DEVICE MARKET BY APPLICATION 2012-2022 ($ MILLION) 31
TABLE 2 GLOBAL ANGIOGRAPHY DEVICE MARKET BY THERAPEUTIC 2012-2022 ($ MILLION) 31
TABLE 3 GLOBAL ANGIOGRAPHY DEVICE MARKET BY DIAGNOSTIC 2012-2022 ($ MILLION) 32
TABLE 4 GLOBAL ANGIOGRAPHY DEVICE MARKET BY END USER 2012-2022 ($ MILLION) 32
TABLE 5 GLOBAL ANGIOGRAPHY DEVICE MARKET BY ACADEMIC RESEARCH LABORATORIES 2012-2022 ($ MILLION) 32
TABLE 6 GLOBAL ANGIOGRAPHY DEVICE MARKET BY HOSPITAL 2012-2022 ($ MILLION) 32
TABLE 7 GLOBAL ANGIOGRAPHY DEVICE MARKET BY DIAGNOSTIC CENTERS 2012-2022 ($ MILLION) 32
TABLE 8 GLOBAL ANGIOGRAPHY DEVICE MARKET BY TYPE OF PROCEDURE 2012-2022 ($ MILLION) 32
TABLE 9 GLOBAL ANGIOGRAPHY DEVICE MARKET BY MICRO ANGIOGRAPHY 2012-2022 ($ MILLION) 32
TABLE 10 GLOBAL ANGIOGRAPHY DEVICE MARKET BY NON-COONARY ANGIOGRAPHY 2012-2022 ($ MILLION) 32
TABLE 11 GLOBAL ANGIOGRAPHY DEVICE MARKET BY PERIPHERAL ANGIOGRAPHY 2012-2022 ($ MILLION) 32
TABLE 12 GLOBAL ANGIOGRAPHY DEVICE MARKET BY NEURO-VASCULAR ANGIOGRAPHY 2012-2022 ($ MILLION) 32
TABLE 13 GLOBAL ANGIOGRAPHY DEVICE MARKET BY CORONARY ANGIOGRAPHY 2012-2022 ($ MILLION) 32
TABLE 14 GLOBAL ANGIOGRAPHY DEVICE MARKET BY OTHER PROCEDURES 2012-2022 ($ MILLION) 32
TABLE 15 GLOBAL ANGIOGRAPHY DEVICE MARKET BY PRODUCT 2012-2022 ($ MILLION) 32
TABLE 16 GLOBAL ANGIOGRAPHY DEVICE MARKET BY GUIDE WIRE 2012-2022 ($ MILLION) 32
TABLE 17 GLOBAL ANGIOGRAPHY DEVICE MARKET ANGIOGRAPHY SYSTEM 2012-2022 ($ MILLION) 32
TABLE 18 GLOBAL ANGIOGRAPHY DEVICE MARKET BY CATHETER TUBE 2012-2022 ($ MILLION) 32
TABLE 19 GLOBAL ANGIOGRAPHY DEVICE MARKET BY BALLOON 2012-2022 ($ MILLION) 32
TABLE 20 GLOBAL ANGIOGRAPHY DEVICE MARKET BY OTHERS 2012-2022 ($ MILLION) 33
TABLE 21 GLOBAL ANGIOGRAPHY DEVICE MARKET BY TECHNOLOGY 2012-2022 ($ MILLION) 33
TABLE 22 GLOBAL ANGIOGRAPHY DEVICE MARKET BY MR ANGIOGRAPHY DEVICES 2012-2022 ($ MILLION) 33
TABLE 23 GLOBAL ANGIOGRAPHY DEVICE MARKET BY X-RAY ANGIOGRAPHY DEVICES 2012-2022 ($ MILLION) 33
TABLE 24 GLOBAL ANGIOGRAPHY DEVICE MARKET BY FLAT-PANEL DETECTORS 2012-2022 ($ MILLION) 33
TABLE 25 GLOBAL ANGIOGRAPHY DEVICE MARKET BY IMAGE INTENSIFIERS 2012-2022 ($ MILLION) 33
TABLE 26 GLOBAL ANGIOGRAPHY DEVICE MARKET BY CT ANGIOGRAPHY DEVICES 2012-2022 ($ MILLION) 33
TABLE 27 GLOBAL ANGIOGRAPHY DEVICE MARKET BY SYMPTOM 2012-2022 ($ MILLION) 33
TABLE 28 GLOBAL ANGIOGRAPHY DEVICE MARKET BY VALVULAR HEART DISEASE 2012-2022 ($ MILLION) 33
TABLE 29 GLOBAL ANGIOGRAPHY DEVICE MARKET BY CONGESTIVE HEART FAILURE 2012-2022 ($ MILLION) 33
TABLE 30 GLOBAL ANGIOGRAPHY DEVICE MARKET BY CONGENITAL HEART FAILURE 2012-2022 ($ MILLION) 33
TABLE 31 GLOBAL ANGIOGRAPHY DEVICE MARKET BY OTHER SYMPTOMS 2012-2022 ($ MILLION) 33
TABLE 32 GLOBAL ANGIOGRAPHY DEVICE MARKET REGIONAL OUTLOOK 2012-2022 ($ MILLION) 33
TABLE 33 GLOBAL ANGIOGRAPHY DEVICE MARKET BY REGION 2012-2022 ($ MILLION) 33
TABLE 34 NORTH AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 33
TABLE 35 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 33
TABLE 36 NORTH AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 33
TABLE 37 U.S. MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
TABLE 38 U.S. MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 34
TABLE 39 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
TABLE 40 CANADA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 34
TABLE 41 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
TABLE 42 EUROPE MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 34
TABLE 43 EUROPE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 34
TABLE 44 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
TABLE 45 GERMANY MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 34
TABLE 46 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
TABLE 47 UK MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 34
TABLE 48 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
TABLE 49 FRANCE MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 34
TABLE 50 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
TABLE 51 SPAIN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 34
TABLE 52 RUSSIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 34
TABLE 53 RUSSIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 34
TABLE 54 OTHERS MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 55 OTHERS MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 56 ASIA PACIFIC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 57 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY REGION 2012-2022 ($ MILLION) 35
TABLE 58 ASIA PACIFIC MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 59 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 60 CHINA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 61 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 62 INDIA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 63 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 64 JAPAN MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 35
TABLE 65 SOUTH KOREA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 66 SOUTH KOREA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($MILLION) 35
TABLE 67 OTHER MARKET ESTIMATES AND FORECASTS 2012-2022 ($ MILLION) 35
TABLE 68 OTHER MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 69 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 35
TABLE 70 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 35
TABLE 71 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 72 LATIN AMERICA MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36
TABLE 73 BRAZIL MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
TABLE 74 BRAZIL MARKET ESTIMATES AND FORECAST BY APPLICATION 2012-2022 ($ MILLION) 36

FIGURE 1 MARKET SHARE BY REGIONS 36
FIGURE 2 UNITED STATES MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
FIGURE 3 CANADA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
FIGURE 4 EUROPE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
FIGURE 5 GERMANY MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
FIGURE 6 UK MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
FIGURE 7 FRANCE MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
FIGURE 8 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
FIGURE 9 APAC MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
FIGURE 10 CHINA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
FIGURE 11 INDIA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
FIGURE 12 JAPAN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 36
FIGURE 13 SPAIN MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 14 MIDDLE EAST & AFRICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 15 LATIN AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37
FIGURE 16 BRAZIL AMERICA MARKET ESTIMATES AND FORECAST 2012-2022 ($ MILLION) 37

Choose License


Contact Information

: 24/7 Research Support

: sales@briskinsights.com

: +448081890034 (UK)